Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases

INTRODUCTION: Brain metastases (BM) severely affect the prognosis and quality of life of patients with NSCLC. Recently, molecularly targeted agents were found to have promising activity against BM in patients with NSCLC whose primary tumors carry “druggable” mutations. Nevertheless, it remains criti...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicoś, Marcin, Harbers, Luuk, Patrucco, Enrico, Kramer-Drauberg, Maximilian, Zhang, Xiaolu, Voena, Claudia, Kowalczyk, Anna, Bożyk, Aleksandra, Pęksa, Rafał, Jarosz, Bożena, Szumiło, Justyna, Simonetti, Michele, Żuk, Monika, Wasąg, Bartosz, Reszka, Katarzyna, Duchnowska, Renata, Milanowski, Janusz, Chiarle, Roberto, Bienko, Magda, Krawczyk, Paweł, Jassem, Jacek, Ambrogio, Chiara, Crosetto, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763853/
https://www.ncbi.nlm.nih.gov/pubmed/36561283
http://dx.doi.org/10.1016/j.jtocrr.2022.100435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763853/
https://www.ncbi.nlm.nih.gov/pubmed/36561283
http://dx.doi.org/10.1016/j.jtocrr.2022.100435

Ejemplares similares